文献速递神经肿瘤脊柱脊髓外科

脊髓胶质瘤的分子研究进展及18F-FDG-PET/CT在其诊断中的作用

Molecular insights and the role of 18F-FDG-PET/CT in the diagnosis of spinal gliomas.
PubMed 文献 · Acta Neurochir (Wien) · 2024-03-27

本研究纳入2016年1月至2023年11月在名古屋大学医院神经外科接受18F-FDG-PET检查的脊髓胶质瘤患者,按病理和分子研究分为高级别与低级别两组,比较高、低级别胶质瘤的SUVmax,并用ROC曲线评估诊断效能。结果显示高级别组SUVmax为6.76±0.72,低级别组为4.02±1.78,两组差异有统计学意义;SUVmax截断值为5.650,AUC约为0.909,敏感性和阴性预测值均为1.0。

要点

  • 高级别脊髓胶质瘤SUVmax为6.76±0.72,低级别为4.02±1.78,两组差异有统计学意义。
  • ROC曲线得出SUVmax截断值5.650,AUC约为0.909。
  • 以该截断值诊断时敏感性1.0、阴性预测值1.0,特异性0.909、阳性预测值0.875。

核心结论

  • 本研究表明18F-FDG-PET在脊髓胶质瘤评估中表现出很高的敏感性和阴性预测值。
  • 这些发现对使用18F-FDG-PET/CT对脊髓胶质瘤进行定性评估具有潜在意义。
  • 在无法通过分子分析进行详细诊断的情况下,该影像模态可能有助于及时做出治疗决策。

研究设计与样本

  • 本研究纳入2016年1月至2023年11月在名古屋大学医院神经外科接受18F-FDG-PET检查并诊断为脊髓胶质瘤的患者。
  • 根据病理和分子研究将胶质瘤分为高级别和低级别两组。
  • 对肿瘤的最大标准化摄取值(SUVmax)进行定量,并用受试者工作特征(ROC)曲线表示。

主要发现

  • 共纳入18例参与者。
  • 7例为高级别胶质瘤,SUVmax为6.76±0.72;11例为低级别胶质瘤,SUVmax为4.02±1.78,两组差异有统计学意义。
  • ROC曲线得出SUVmax截断值为5.650,曲线下面积(AUC)约为0.909。
  • 基于该截断值,诊断性能结果为敏感性1.0、阴性预测值1.0,特异性0.909、阳性预测值0.875。

关键数值与推荐

  • 高级别胶质瘤组SUVmax为6.76±0.72,低级别胶质瘤组SUVmax为4.02±1.78。
  • SUVmax截断值为5.650,AUC约为0.909。
  • 基于截断值5.650,敏感性1.0、阴性预测值1.0,特异性0.909、阳性预测值0.875。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In recent years, molecular findings on spinal gliomas have become increasingly important. This study aimed to investigate the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in the diagnosis of spinal glioma. METHODS: This study included patients diagnosed with spinal cord glioma who underwent 18F-FDG-PET examination at the Department of Neurosurgery, Nagoya University Hospital between January 2016 and November 2023. The gliomas were divided into two groups, high-grade and low-grade, based on pathological and molecular studies. The maximum standardized uptake values (SUVmax) of the tumors were quantified and subsequently represented using receiver operating characteristic (ROC) curves. RESULTS: Eighteen participants were included in this study. Of the participants, seven had high-grade glioma with an SUVmax of 6.76 ± 0.72, and eleven had low-grade glioma with an SUVmax of 4.02 ± 1.78, and a statistically significant difference between the two groups. The ROC curve delineated an SUVmax cutoff value of 5.650, with an area under the curve (AUC) of approximately 0.909. Based on the cutoff value, the results of the diagnostic performance rendered a sensitivity and negative predictive value of 1.0, whereas the specificity and positive predictive value were 0.909 and 0.875, respectively. CONCLUSIONS: The present study shows that 18F-FDG-PET exhibits a markedly sensitive and negative predictive value in the assessment of spinal gliomas. Additionally, these findings have potential implications for the qualitative assessment of spinal gliomas using 18F-FDG-PET/CT. This imaging modality may be useful for making timely treatment decisions in situations where a detailed diagnosis by molecular analysis is not possible.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Nagashima Y, Nishimura Y, Eguchi K, et al. Molecular insights and the role of 18F-FDG-PET/CT in the diagnosis of spinal gliomas. Acta Neurochir (Wien). 2024. PMID: 38538929. doi:10.1007/s00701-024-06039-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。